Helicobacter pylori Therapy
Author:
Publisher
Springer Japan
Link
http://link.springer.com/content/pdf/10.1007/978-4-431-55936-8_20
Reference66 articles.
1. Borody TJ, Pang G, Wettstein AR, Clancy R, Herdman K, Surace R, Llorente R, Ng C (2006) Efficacy and safety of rifabutin-containing ‘rescue therapy’ for resistant Helicobacter pylori infection. Aliment Pharmacol Ther 23:481–488
2. Chey WD, Wong BC (2007) American College of Gastroenterology guideline on the management of Helicobacter Pylori infection. Am J Gastroenterol 102:1808
3. Chuah SK, Tai WC, Hsu PI, Wu DC, Wu KL, Kuo CM, Chiu YC, Hu ML, Chou YP, Kuo YH, Liang CM, Chiu KW, Hu TH (2012) The efficacy of second-line anti Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment – a pilot study. Helicobacter 17:374–381
4. De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi E, Panella C, Morini S (2001) Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 33:676–679
5. De Francesco V, Hassan C, Ridola L, Giorgio F, Ierardi E, Zullo A (2014) Sequential, concomitant and hybrid first-line therapies for H. pylori eradication: a prospective, randomized study. J Med Microbiol 63:748–752
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3